Annals of Internal Medicine

Medications

Most US adults with T2D meet criteria for GLP-RAs, SGLT2is

Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...

page 14 from 40